Detalhe da pesquisa
1.
Distorted antibody repertoire developed in the absence of pre-B cell receptor formation.
Biochem Biophys Res Commun
; 495(1): 1411-1417, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191653
2.
Deciphering antigen-responding antibody repertoires by using next-generation sequencing and confirming them through antibody-gene synthesis.
Biochem Biophys Res Commun
; 487(2): 300-306, 2017 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412367
3.
Development of a sensitive novel diagnostic kit for the highly pathogenic avian influenza A (H5N1) virus.
BMC Infect Dis
; 14: 362, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992826
4.
Establishment of Reference Reagents for Single-Radial-Immunodiffusion Assay on the 2022/23 Seasonal Influenza Vaccine in Japan and Their Quality Validation.
Jpn J Infect Dis
; 77(2): 105-111, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030271
5.
Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
Biochem Biophys Res Commun
; 418(1): 38-43, 2012 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22226969
6.
Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards.
Biologicals
; 40(1): 96-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22244521
7.
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
Nat Med
; 10(3): 290-3, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14981511
8.
[The latest trend and prospects of development of influenza vaccine].
Nihon Rinsho
; 69(9): 1567-70, 2011 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-21922754
9.
Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide.
Bioorg Med Chem
; 18(14): 5379-90, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20538468
10.
[Trends and perspectives in development of influenza vaccines].
Nihon Rinsho
; 68(9): 1697-701, 2010 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-20845750
11.
Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine.
Heliyon
; 5(1): e01113, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623129
12.
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing.
J Vis Exp
; (145)2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933062
13.
Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan.
Vaccine
; 37(43): 6573-6579, 2019 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31506194
14.
Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer.
J Epidemiol
; 18(4): 160-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18603824
15.
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.
Microbes Infect
; 9(11): 1333-40, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17890128
16.
Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes.
Int J Exp Pathol
; 88(6): 403-14, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18039277
17.
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Microbes Infect
; 8(12-13): 2706-14, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16968669
18.
Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies.
Jpn J Infect Dis
; 58(2): 88-94, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15858286
19.
Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin.
PLoS One
; 9(6): e99201, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24945805
20.
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.
Vaccine
; 32(37): 4713-25, 2014 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582632